Point72 Asset Management
CORT icon

Point72 Asset Management’s Corcept Therapeutics CORT Stock Holding History

Point72 Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26M Buy
+56,181
New +$2.1M ﹤0.01% 2226
2025
Q1 		– Hold
0
– – – 2159
2024
Q4 		– Hold
0
– – – 2176
2023
Q4 		– Sell
-1,690
Closed -$46K – 2281
2023
Q3 		$46K Buy
1,690
+1,025
+154% +$29.7K ﹤0.01% 2151
2023
Q2 		$14.8K Sell
665
-1,884
-74% -$43.4K ﹤0.01% 1846
2023
Q1 		$55.2K Buy
+2,549
New +$55.9K ﹤0.01% 1764
2020
Q4 		– Hold
0
– – – 945
2020
Q3 		– Hold
0
– – – 951
2018
Q3 		– Hold
0
– – – 1050
2018
Q2 		– Hold
0
– – – 1005

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return